<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    SCYNEXIS, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About SCYNEXIS, Inc.

    SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $84,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marco Taglietti, M.D.
    • FOUNDED
      1999
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    MedChain Inc

    MedChain Inc

    MedChain's mission is to use blockchain technology to establish a better, more sec...

    MedChain's mission is to use blockchain technol...

    Amount Raised:    $466,896.00
    Fundraising Status:    EC
    Filing Type:    CF
    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new...

    HOOKIPA Pharma Inc. is a clinical stage biophar...

    Filing Type:    PU
    Ansell Ltd.

    Ansell Ltd.

    Ansell Limited provides health and safety protection solutions. The Company has op...

    Ansell Limited provides health and safety prote...

    Filing Type:    PR
    Soliton, Inc.

    Soliton, Inc.

    Soliton, Inc. is a medical device company with a novel and proprietary platform te...

    Soliton, Inc. is a medical device company with ...

    Filing Type:    PU
    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    SelenBio, Inc.

    SelenBio, Inc.

    SelenBio, Inc is a biotechnology company specializing in the prevention of bacteri...

    SelenBio, Inc is a biotechnology company specia...

    Amount Raised:    $94,956.00
    Fundraising Status:    EC
    Filing Type:    CF
    Alseres Pharmaceuticals

    Alseres Pharmaceuticals

    Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and ther...

    Alseres Pharmaceuticals, Inc. is focused on the...

    Amount Raised:    $5,900,000
    Fundraising Status:    VT
    Filing Type:    PU
    Affimed Therapeutics

    Affimed Therapeutics

    At Affimed, we are committed to improving outcomes for patients with cancer. Our s...

    At Affimed, we are committed to improving outco...

    Filing Type:    PU
    CytoDyn Inc.

    CytoDyn Inc.

    CytoDyn is a publicly traded late stage biotechnology company developing innovativ...

    CytoDyn is a publicly traded late stage biotech...

    Filing Type:    PU
    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical compan...

    Spero Therapeutics, Inc. is a multi-asset, clin...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.